Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant Neoplasms
|
1641 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.050 | 1.000 | 5 | 2006 | 2014 | ||||
Primary malignant neoplasm
|
1374 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.040 | 1.000 | 4 | 2009 | 2014 | ||||
Liver carcinoma
|
942 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.030 | 0.667 | 3 | 2012 | 2019 | ||||
Breast Carcinoma
|
2793 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.020 | 1.000 | 2 | 2005 | 2012 | ||||
Malignant neoplasm of breast
|
3417 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.020 | 1.000 | 2 | 2005 | 2012 | ||||
Neoplasm Metastasis
|
327 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.020 | 1.000 | 2 | 2008 | 2013 | ||||
Secondary Neoplasm
|
85 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.020 | 1.000 | 2 | 2008 | 2013 | ||||
Adult Liver Carcinoma
|
72 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Bladder Neoplasm
|
281 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Carcinoma of bladder
|
309 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Carcinoma of lung
|
1204 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Carcinoma, Ovarian Epithelial
|
327 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Chronic Lymphocytic Leukemia
|
291 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Colorectal Carcinoma
|
1962 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Gallbladder Carcinoma
|
75 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Hepatitis C
|
347 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Liver and Intrahepatic Biliary Tract Carcinoma
|
73 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Malignant neoplasm of gallbladder
|
81 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Malignant neoplasm of liver
|
88 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Malignant neoplasm of lung
|
1142 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Malignant neoplasm of ovary
|
315 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Malignant neoplasm of prostate
|
1082 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Mantle cell lymphoma
|
19 | 0.637 | 0.400 | 8 | 23200707 | missense variant | T/G | snv | 0.15 | 0.14 | 0.010 | 1.000 | 1 | 2006 | 2006 |